EUVIMEDEUVIMED entdecken
Crossref

Carboplatin Elicits ROS Responses and Potentially Regulates Translation Program in Cancer Systems

Qin Li, Si Qin, Liuxin Yang, Man Li, Xiang Li iD

Journal of Biochemical and Molecular Toxicology · 2026

DOI: 10.1002/jbt.70989 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2026. Verfasst von Qin Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, P. R. China. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Protein Biosynthesis, Carboplatin, Neoplasms. Die Arbeit nennt 59 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Platinum‐based chemotherapeutic agents display broad‐spectrum and high anticancer activity, the primary target of which is nuclear DNA. During platinum chemotherapeutics, the steady‐state levels of reactive oxygen species (ROS) are generally elevated. However, the pathways by which platinum drugs generate ROS and the biological responses still lack systematic studies. Taking carboplatin as an example, we found that both ROS and antioxidant enzyme expression were elevated, and multiple genes for mitochondrial translation and respiration were up‐regulated to serve as contributors to ROS. Various genes for mitoribosome stress were also up‐regulated, potentially controlling mitochondrial respiration and translation. The expression of single‑stranded DNA‑binding protein 1 ( SSBP1 ), a mitochondrial translational regulator and a potential anti‑cancer target, was up‑regulated in carboplatin‐treated cancer cells and in 22 tumor tissues, probably influencing the efficacy of chemotherapy. The potential crosstalk between mitochondrial translation and ROS response should be crucial for the clinical use of platinum drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reactive Oxygen SpeciesProtein BiosynthesisCarboplatinNeoplasmsAntineoplastic AgentsGene Expression Regulation, NeoplasticHumansMitochondriaCell Line, TumorDNA-Binding Proteins

Stichwörter der Autor:innen

anticancermitochondrial translationplatinum drugs reactive oxygen speciesribosome stress

Substanzen

Reactive Oxygen SpeciesCarboplatinAntineoplastic AgentsDNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Endocrinology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, P. R. China.
  • School of Health Science and Engineering, Hubei University, Wuhan, Hubei, P. R. China.
  • School of Pharmacy, Hubei University of Science and Technology, Xianning, Hubei, P. R. China.

ORCID-Profile: Xiang Li

Zitieren

APA

Li, Q., Qin, S., Yang, L., Li, M., & Li, X. (2026). Carboplatin Elicits ROS Responses and Potentially Regulates Translation Program in Cancer Systems. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70989

Vancouver

Li Q, Qin S, Yang L, Li M, Li X. Carboplatin Elicits ROS Responses and Potentially Regulates Translation Program in Cancer Systems. Journal of Biochemical and Molecular Toxicology. 2026. doi:10.1002/jbt.70989

BibTeX
@article{Li2026,
  author = {Li, Qin and Qin, Si and Yang, Liuxin and Li, Man and Li, Xiang},
  title = {Carboplatin Elicits ROS Responses and Potentially Regulates Translation Program in Cancer Systems},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2026},
  doi = {10.1002/jbt.70989}
}
Kostenlos starten →